X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SHASUN PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SHASUN PHARMA CADILA HEALTHCARE/
SHASUN PHARMA
 
P/E (TTM) x 16.4 123.9 13.2% View Chart
P/BV x 3.7 8.5 43.1% View Chart
Dividend Yield % 1.1 0.2 477.3%  

Financials

 CADILA HEALTHCARE   SHASUN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
SHASUN PHARMA
Mar-14
CADILA HEALTHCARE/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs55894 592.4%   
Low Rs36246 792.8%   
Sales per share (Unadj.) Rs116.3214.2 54.3%  
Earnings per share (Unadj.) Rs17.95.3 334.9%  
Cash flow per share (Unadj.) Rs23.115.8 146.2%  
Dividends per share (Unadj.) Rs3.501.00 350.0%  
Dividend yield (eoy) %0.81.4 53.2%  
Book value per share (Unadj.) Rs85.453.3 160.1%  
Shares outstanding (eoy) m1,023.7456.62 1,808.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.00.3 1,211.4%   
Avg P/E ratio x25.713.1 196.4%  
P/CF ratio (eoy) x19.94.4 449.8%  
Price / Book Value ratio x5.41.3 410.7%  
Dividend payout %19.618.7 104.5%   
Avg Mkt Cap Rs m470,6643,958 11,892.3%   
No. of employees `00011.8NA-   
Total wages/salary Rs m18,5452,164 857.2%   
Avg. sales/employee Rs Th10,072.7NM-  
Avg. wages/employee Rs Th1,569.1NM-  
Avg. net profit/employee Rs Th1,547.7NM-  
INCOME DATA
Net Sales Rs m119,04912,127 981.7%  
Other income Rs m1,132229 493.6%   
Total revenues Rs m120,18112,356 972.6%   
Gross profit Rs m28,4751,009 2,822.0%  
Depreciation Rs m5,388594 907.7%   
Interest Rs m911415 219.5%   
Profit before tax Rs m23,308230 10,147.1%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644-73 -7,761.3%   
Profit after tax Rs m18,292302 6,054.5%  
Gross profit margin %23.98.3 287.5%  
Effective tax rate %24.2-31.7 -76.5%   
Net profit margin %15.42.5 616.7%  
BALANCE SHEET DATA
Current assets Rs m82,0056,884 1,191.2%   
Current liabilities Rs m60,7208,456 718.1%   
Net working cap to sales %17.9-13.0 -138.0%  
Current ratio x1.40.8 165.9%  
Inventory Days Days7362 118.7%  
Debtors Days Days98108 91.4%  
Net fixed assets Rs m83,7034,970 1,684.1%   
Share capital Rs m1,024113 903.8%   
"Free" reserves Rs m86,4212,875 3,006.1%   
Net worth Rs m87,4453,020 2,895.3%   
Long term debt Rs m25,5511,817 1,405.9%   
Total assets Rs m180,65313,347 1,353.5%  
Interest coverage x26.61.6 1,711.5%   
Debt to equity ratio x0.30.6 48.6%  
Sales to assets ratio x0.70.9 72.5%   
Return on assets %10.65.4 197.8%  
Return on equity %20.910.0 209.1%  
Return on capital %22.013.3 165.1%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m42,6835,843 730.5%   
Fx outflow Rs m11,2422,173 517.3%   
Net fx Rs m31,4413,669 856.8%   
CASH FLOW
From Operations Rs m9,193398 2,312.1%  
From Investments Rs m-9,737-1,635 595.5%  
From Financial Activity Rs m5151,309 39.4%  
Net Cashflow Rs m-2971 -40.7%  

Share Holding

Indian Promoters % 74.8 39.2 190.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.6 230.6%  
FIIs % 5.9 17.6 33.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 39.6 27.8%  
Shareholders   44,069 20,750 212.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  BIOCON LTD  UNICHEM LAB  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 50.4% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 50.4% YoY). Sales on the other hand came in at Rs 33 bn (up 28.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Feb 22, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS